Creo Medical Group PLC
LSE:CREO
Relative Value
The Relative Value of one
CREO
stock under the Base Case scenario is
hidden
GBX.
Compared to the current market price of 17.5 GBX,
Creo Medical Group PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
CREO Competitors Multiples
Creo Medical Group PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Creo Medical Group PLC
LSE:CREO
|
72.2m GBP | 33.5 | 4.4 | -6.1 | -5.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD | 4.3 | 29.4 | 16.7 | 22.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.6B USD | 17.3 | 61.1 | 46.6 | 56.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
136.5B USD | 5.4 | 42.1 | 21.4 | 25.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.8B USD | 3.8 | 27.7 | 15.5 | 22.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.1B USD | 5.8 | 40.2 | 23.9 | 32.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD | 2.7 | 35.6 | 13 | 22.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.4B EUR | 2 | 21.9 | 12.1 | 17.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.6B USD | 12 | 48.7 | 34.8 | 38.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.7 | 33.2 | 23.6 | 25.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
39.5B USD | 7.3 | 26.6 | 18.8 | 20.9 |